We are live on ! Find out more
VRCA icon

Verrica Pharmaceuticals
VRCA

74 hedge funds and large institutions have $13M invested in Verrica Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 10 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 10

0.1% less ownership

Funds ownership: 3.32% → 3.21% (-0.1%)

9% less funds holding

Funds holding: 81 → 74 (-7)

38% less capital invested

Capital invested by funds: $21M → $13M (-$7.95M)

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

Holders
74
Holders Change
-7
Holders Change %
-8.64%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
30
Reduced
10
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CP
Caligan Partners
New York
+$1.01M
2
UBS Group
UBS Group
Switzerland
+$398K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$350K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$311K
5
Millennium Management
Millennium Management
New York
+$256K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$2.27M
2
HCM
Heights Capital Management
California
-$246K
3
AC
Armistice Capital
New York
-$229K
4
Morgan Stanley
Morgan Stanley
New York
-$189K
5
Renaissance Technologies
Renaissance Technologies
New York
-$163K
Name Holding Trade Value Shares
Change 		Change in
Stake
SWM
51
Spire Wealth Management
Virginia
$2.5K +$19 +3 +0.5%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$2K +$1.92K +297 +86%
Carson Wealth (CWM LLC)
53
Carson Wealth (CWM LLC)
Nebraska
$2K +$2.18K +337 +527%
PNC Financial Services Group
54
PNC Financial Services Group
Pennsylvania
$1.91K +$2.71K +419 +3,492%
PFSRSONJ
55
Police & Firemen's Retirement System of New Jersey
New Jersey
$1.68K – – –
SL
56
Salomon & Ludwin
Virginia
$1.28K – – –
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$1.22K +$52 +8 +3%
Legal & General Group
58
Legal & General Group
United Kingdom
$1.11K – – –
NECFA
59
New England Capital Financial Advisors
Connecticut
$885 – – –
Northwestern Mutual Wealth Management
60
Northwestern Mutual Wealth Management
Wisconsin
$779 +$1.14K +176 New
AIP
61
Ameritas Investment Partners
Nebraska
$762 – – –
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$607 – – –
CCM
63
Coldstream Capital Management
Washington
$315 +$459 +71 New
Deutsche Bank
64
Deutsche Bank
Germany
$260 – – –
Osaic Holdings
65
Osaic Holdings
Arizona
$249 -$129 -20 -26%
EWA
66
EverSource Wealth Advisors
Alabama
$56 +$84 +13 New
Jones Financial Companies
67
Jones Financial Companies
Missouri
$32 – – –
Group One Trading
68
Group One Trading
Illinois
$14 – – –
MCM
69
MAI Capital Management
Ohio
$10 – – –
SCM
70
Sterling Capital Management
North Carolina
$8 – – –
TWD
71
True Wealth Design
Ohio
$4 +$6 +1 New
SS
72
SBI Securities
Japan
$2 -$6 -1 Closed
PA
73
Perceptive Advisors
New York
– -$2.27M -324,967 Closed
HCM
74
Heights Capital Management
California
– -$246K -35,114 Closed
Renaissance Technologies
75
Renaissance Technologies
New York
– -$163K -23,330 Closed
1 2
3
4

VRCA Hedge Fund Activity: Q1 2025 in Review

74 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Verrica Pharmaceuticals (VRCA) for Q1 2025, worth a combined $13M — down 38% from $21M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of VRCA and 9 opened new positions — a net loss of 7 holders — while 10 trimmed existing stakes and 30 added.

The largest buyer was Caligan Partners, adding an estimated $1.01M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $2.27M sold.

  • 74 institutional investors held Verrica Pharmaceuticals (VRCA) as of Q1 2025, down from 81 in Q4 2024.
  • Funds reported $13M of Verrica Pharmaceuticals stock for Q1 2025, down 38% quarter-over-quarter.
  • 9 funds opened new Verrica Pharmaceuticals positions in Q1 2025 and 16 closed out, a net change of -7 holders.
  • The largest Verrica Pharmaceuticals buyer in Q1 2025 was Caligan Partners, an estimated $1.01M added.
  • The largest Verrica Pharmaceuticals seller in Q1 2025 was Perceptive Advisors, an estimated $2.27M sold.

Based on aggregated 13F filings for Q1 2025.